Run. Yu, et.al., Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice., PloS one, 2011, 6

http://rdf.ncbi.nlm.nih.gov/pubmed/21853126

Run. Yu, et.al., Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice., PloS one, 2011, 6

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal pancreatic acinar cell morphology_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0009146DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased liver weight_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0003402DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• increased pancreas tumor incidence_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0009153DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• abnormal exocrine gland morphology_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0013558DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• abnormal pancreatic alpha cell morphology_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0005216DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased abdominal adipose tissue amount_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0008853DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased body weight_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0001262DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• increased glucagonoma incidence_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0003365DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• enlarged pancreatic islets_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0009171DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• enlarged pancreas_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0003450DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased subcutaneous adipose tissue amount_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0008844DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• increased pancreatic beta cell proliferation_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0011819DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• pancreatic islet hyperplasia_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0005491DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased circulating insulin level_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0002727DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased circulating glucose level_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0005560DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• increased circulating glucagon level_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0002712DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• abnormal pancreatic alpha cell differentiation_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0009179DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased susceptibility to hepatic steatosis_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0002310DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• decreased susceptibility to weight gain_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0010182DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp
• abnormal pancreatic islet morphology_Gcgr<tm1Jcp>/Gcgr<tm1Jcp>
  http://metadb.riken.jp/0005215DBA1LacJGcgrtm1JcpGcgrtm1JcpGcgrtm1JcpGcgrtm1Jcp